Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Scavenging Mechanism on Methylglyoxal in T2DM
NCT02548741Unknown
- Sponsor
- University of Arizona
- Start
- Sep 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by University of Arizona. Primary endpoint: Plasma methylglyoxal concentration at 6 weeks. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02548741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02548741.